Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology July 27, 2023
Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology July 11, 2023
Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial May 22, 2023
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine April 17, 2023
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting March 27, 2023
Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders March 2, 2023
Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology February 27, 2023